Milled Flaxseed (Linum usitatissimum)

Milled flaxseed (Linum usitatissimum) delivers bioavailable lignans, alpha-linolenic acid (ALA), and soluble fiber that collectively modulate cholesterol metabolism and vascular function. Its primary mechanisms include enterolactone-mediated estrogen receptor activity, ALA-driven eicosanoid pathway modulation, and soluble fiber binding of bile acids in the gut.

Origin & History

Milled flaxseed derives from the seeds of Linum usitatissimum (common flax), an annual plant native to the Mediterranean region and cultivated worldwide for its oil-rich seeds. The seeds are harvested, dried, and mechanically milled into a fine powder without chemical extraction, preserving whole-seed components including oils, lignans, and fibers.

Historical & Cultural Context

Flaxseed (Linum usitatissimum) has been used in traditional medicine systems for centuries, primarily for laxative, anti-inflammatory, and cardiovascular benefits. Modern clinical trials build upon these traditional applications, particularly for metabolic and inflammatory conditions.

Health Benefits

• Cardiovascular protection: Clinical trials show 6-11% total cholesterol reduction and blood pressure improvements (moderate evidence from multiple RCTs)
• Lipid profile optimization: Systematic reviews demonstrate improvements in dyslipidemia markers with 30-50g daily intake (moderate evidence)
• Blood glucose regulation: Reviews indicate beneficial effects on diabetes and insulin sensitivity (preliminary evidence from clinical trials)
• Anti-inflammatory potential: Contains lignans that induce apoptosis and cell cycle arrest in cancer cell lines, though CRP levels unchanged in meta-analysis of 17 RCTs (mixed evidence)
• Digestive health support: High fiber content provides laxative effects, though specific GI outcomes not detailed in reviewed RCTs (traditional use evidence)

How It Works

The soluble fiber (mucilage) in milled flaxseed binds bile acids in the intestinal lumen, forcing hepatic upregulation of LDL receptors to synthesize replacement bile acids from circulating cholesterol, thereby lowering LDL-C. Alpha-linolenic acid (ALA, 18:3n-3) competitively inhibits arachidonic acid conversion via COX and LOX enzymes, shifting eicosanoid production toward less pro-inflammatory prostaglandins and reducing thromboxane A2-mediated vasoconstriction. Secoisolariciresinol diglucoside (SDG), the primary lignan, is converted by gut microbiota to enterolactone and enterodiol, which weakly bind estrogen receptors (ERα/ERβ) and upregulate sex hormone-binding globulin, modulating hormonal and inflammatory signaling.

Scientific Research

A 2019 meta-analysis of 17 RCTs (n=1256) found no significant effect on C-reactive protein levels despite low risk of bias (PMID: 30697250). Another systematic review of 32 RCTs showed mixed effects on inflammatory biomarkers (PMID: 31115436), while a comprehensive review reported valuable cardiovascular, metabolic, and lipid benefits (PMID: 32436825).

Clinical Summary

Multiple RCTs and systematic reviews support cardiovascular benefits of milled flaxseed at doses of 30-50g daily, with pooled analyses of 28+ RCTs demonstrating 6-11% reductions in total cholesterol and LDL-C in hyperlipidemic adults. A 2015 randomized double-blind trial (n=110) found 30g/day of milled flaxseed reduced systolic blood pressure by 10 mmHg and diastolic by 7 mmHg in peripheral artery disease patients over 6 months. Evidence for triglyceride reduction is mixed; a 2019 meta-analysis of 40 trials found modest but inconsistent TG reductions, suggesting response variability based on baseline metabolic status. Overall evidence strength is moderate—effects are real but magnitude varies with dose, processing method (whole vs. milled), and individual gut microbiome composition affecting SDG-to-enterolactone conversion.

Nutritional Profile

{"macronutrients": {"protein": "18.3g per 100g", "total_fat": "42.2g per 100g", "saturated_fat": "3.7g per 100g", "monounsaturated_fat": "7.5g per 100g", "polyunsaturated_fat": "28.7g per 100g", "omega_3_fatty_acids": "22.8g per 100g", "carbohydrates": "28.9g per 100g", "fiber": "27.3g per 100g"}, "micronutrients": {"calcium": "255mg per 100g", "iron": "5.7mg per 100g", "magnesium": "392mg per 100g", "phosphorus": "642mg per 100g", "potassium": "813mg per 100g", "zinc": "4.3mg per 100g", "vitamin_B1": "1.64mg per 100g", "vitamin_B6": "0.47mg per 100g", "folate": "87\u00b5g per 100g"}, "bioactive_compounds": {"lignans": "0.3g per 100g", "bioavailability_notes": "Omega-3 fatty acids are present as alpha-linolenic acid (ALA), which requires conversion in the body to EPA and DHA. Lignan content contributes to antioxidant properties."}}

Preparation & Dosage

Clinically studied doses: 30-50g/day of milled flaxseed for cardiovascular and metabolic effects, with trials lasting 2 weeks to 12 months. Higher doses (30-40g/day) used specifically for lipid profile improvements. No standardization to specific compounds was consistently specified in trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Psyllium husk, Fish oil, Garlic extract, Coenzyme Q10, Plant sterols

Safety & Interactions

Milled flaxseed is generally well tolerated; the most common side effects are dose-dependent gastrointestinal symptoms including bloating, flatulence, and loose stools, particularly when initiating intake above 15g/day without adequate hydration. Its mucilage content can delay absorption of oral medications including warfarin, metformin, and thyroid hormones—patients should separate flaxseed intake from medications by at least 2 hours. Due to weak phytoestrogenic activity from SDG-derived lignans, caution is advised for individuals with hormone-sensitive conditions such as estrogen receptor-positive breast cancer, though evidence of clinical harm at food-level doses is not established. Flaxseed is considered likely safe in pregnancy at dietary amounts, but high supplemental doses are not recommended due to theoretical uterine-stimulating effects from ALA; individuals on anticoagulants should monitor INR as ALA may mildly potentiate bleeding risk.